Trial intelligence / Profile preview

Azithromycin vs Amoxicillin-Clavulanic Acid in Chronic Bronchitis Exacerbation

NCT00649831Phase 3Completed

Sponsor
Pfizer
Start
Oct 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of azithromycin in chronic bronchitis (CB), sponsored by Pfizer. Started Oct 2002; status: completed.

02

Drugs

azithromycin
03

Conditions

chronic bronchitis (CB)

Beyond the preview

Go deeper on NCT00649831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00649831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call